bioRxivCell BiologyPreprint
Regulatory elements of pancreas development license the initiation of pancreatic ductal adenocarcinoma
Marta Ballester, Anita KurillaiD, Yifan DaiiD, H. Carlo MaureriD, Elisa EspinetiD, Kristina Høj, Aida Marisch Delgado, Philip Allan SeymouriD, Saynab Omar, Charlotte Vestrup RiftiD, Jane Preuss HasselbyiD, Pia Helene KlauseniD, Peter VilmanniD, Albin SandeliniD, Luís ArnesiD
Abstract
Cellular plasticity and transitional cellular states are crucial for tissue regeneration across multiple organs. In the pancreas, oncogenic Kras hijacks this program, acting on tissue-specific enhancers to prevent the resolution of acinar-to-ductal metaplasia (ADM) and lock regeneration into a pro-inflammatory state that progresses to cancer. Enhancer transcription, an early event during cellular state transitions, can generate stable enhancer-associated long noncoding RNAs (lncRNAs) positioned near key transcription factors and chromatin contact boundaries, often enriched for disease-associated variants. While enhancer-associated lncRNAs have been implicated in transcriptional regulation and genome organization, their role in pancreas regeneration and cancer initiation has remained unexplored. In this study, we investigated the expression of epithelial long noncoding RNAs (lncRNAs) and their target genes in PDAC precursor lesion formation. We focus on lncRNAs transcribed from enhancer elements near cell identity transcription factors. We demonstrate that LINC00673, expressed from a Sox9-associated super-enhancer during pancreatic development, is reactivated in PDAC. Conditional deletion of LINC00673 in the murine pancreatic epithelium accelerates resolution of ADM and significantly impairs PDAC initiation. Notably, LINC00673 harbors a variant associated with risk of developing PDAC. Our study identifies a critical function of LINC00673 in regulating both cell-autonomous and non-cell-autonomous processes during pancreas regeneration and Kras-driven cancer initiation. Furthermore, we highlight a previously unrecognized role of transcribed super-enhancers in facilitating long-range gene regulation during pancreatic cancer initiation. These findings reveal a novel regulatory layer linking developmental enhancer activity, cellular plasticity and pancreatic disease progression. TeaserLong noncoding RNAs from developmental enhancers play a role in long-range gene regulation with crucial biological impacts in development and cancer. Grant supportThis project has been supported by the Danish Cancer Society (R302-A17481). LA is supported by core funding of the Biotech Research and Innovation Center, the Danish Cancer Society (R302-A17481, R322-A17.350), The Novo Nordisk Foundation (NNF21OC0070884) and The Innovation Fund (Eurostars 2807). The Novo Nordisk Foundation Center for Stem Cell Biology was supported by Novo Nordisk Foundation grants NNF17CC0027852.
- organism: mouse
- assay: long-read sequencing
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: experimental assay
- approach: genetic perturbation / CRISPR
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- LncRNA LINC00941 Links Oncogenic KRAS Signaling to Aggressiveness and Chemoresistance in Pancreatic Cancer
Thalita Bueno Corrêa, Gabriel Lucas da Fonseca, … Daniela S. Daniela Sanchez Bassères·bioRxiv·Sep 29, 2025
- Long Noncoding RNAs Preserve Pancreatic Cancer Identity and Resist Cell Fate Conversion
Dmytro Grygoryev, Seung-Won Lee, … Jungsun Kim·bioRxiv·Jun 25, 2025
- p73 activates transcriptional signatures of basal lineage identity and ciliogenesis in pancreatic ductal adenocarcinoma
S. K. Hur, T. D. D. Somerville, … C. R. Vakoc·bioRxiv·Apr 20, 2023
- KRAS-mediated upregulation of CIP2A promotes suppression of PP2A-B56α to initiate pancreatic cancer development
S. L. Tinsley, R. A. Shelley, … B. Allen-Petersen·bioRxiv·Jul 1, 2023
- Drug-Induced p53 Activation Limits Pancreatic Cancer Initiation
Jennifer J. Twardowski, Thomas I. Heist, … Stephano S. Mello·bioRxiv·May 29, 2024
- PRDM3 attenuates pancreatitis and pancreatic tumorigenesis by regulating inflammatory response